These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3802017)

  • 1. Zinc and anergy in pediatric Hodgkin's disease in Turkey.
    Cavdar AO; Babacan E; Gözdaşoğlu S; Erten J; Cin S; Arcasoy A; Ertem U
    Cancer; 1987 Jan; 59(2):305-9. PubMed ID: 3802017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc status and cellular immunity in pediatric Hodgkin's disease.
    Cavdar AO; Babacan E; Ertem U; Gözdasoğlu S; Arcasoy A
    Prog Clin Biol Res; 1983; 129():207-20. PubMed ID: 6657703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum zinc levels, lymphocyte counts and functions in pediatric Hodgkin's disease.
    Babacan E; Cavdar AO; Arcasoy A
    Boll Ist Sieroter Milan; 1977 Jul; 56(3):228-34. PubMed ID: 901636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of correlation between skin reactivity and T lymphocytes and monocytes in Hodgkin's disease.
    Müftüoğlu AU; Yalçin B
    Acta Haematol; 1980; 63(5):286-8. PubMed ID: 6774558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin tests in childhood lymphoma and neuroblastoma.
    Gasparini M; Bardare M; Fossati Bellani F
    Tumori; 1976; 62(4):429-34. PubMed ID: 1020049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
    Rambotti P; Velardi A; Spinozzi F; Falini B; Martelli MF
    Boll Ist Sieroter Milan; 1979 Mar; 58(1):90-9. PubMed ID: 552840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing features of the immunology of Hodgkin's disease in children.
    Tan CT; De Sousa M; Good RA
    Cancer Treat Rep; 1982 Apr; 66(4):969-75. PubMed ID: 7074657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosette and blastogenesis inhibition by plasma from Hodgkin's disease and other malignancies. Positive correlation in State I and II Hodgkin's disease.
    Sinclair T; Ezdinli EZ; Boonlayangoor P; Wasser LP; Han T
    Cancer; 1983 Jan; 51(2):238-44. PubMed ID: 6336976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disorders of cellular immunity in Hodgkin's disease].
    Burchardt K
    Pol Arch Med Wewn; 1981 Aug; 66(2):133-41. PubMed ID: 7033936
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated immunity, serum and lymphocyte zinc levels in Hodgkin's disease.
    Acar S; Ersey F; Sanal O; Bechel I; Gebri N
    Prog Clin Biol Res; 1983; 129():255-60. PubMed ID: 6657707
    [No Abstract]   [Full Text] [Related]  

  • 12. Cellular immunity in Hodgkin's disease.
    Advani SH; D'Silva H; Gothoskar BP; Dinshaw KA; Nair CN; Gopalkrishna R; Talwalkar GV; Desai PB
    Cancer; 1979 Feb; 43(2):492-9. PubMed ID: 421176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular immunity in Hodgkin's disease: comparison of cutaneous reactivity and lymphoproliferative responses tp phytohemagglutinin.
    Winkelstein A; Mikulla JM; Sartiano GP; Ellis LD
    Cancer; 1974 Sep; 34(3):549-53. PubMed ID: 4850927
    [No Abstract]   [Full Text] [Related]  

  • 14. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune status of untreated patients with Hodgkin's disease and prognosis.
    Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Persisting deficiency of cell mediated immunity in Hodgkin's disease in complete remission (author's transl)].
    Lang JM; Bigel P; Giron C; Faradji A; Oberling F; Mayer S
    Nouv Presse Med; 1979 Nov; 8(44):3629-32. PubMed ID: 316521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune function of successfully treated lymphoma patients.
    King GW; Yanes B; Hurtubise PE; Balcerzak SP; LoBuglio AF
    J Clin Invest; 1976 Jun; 57(6):1451-60. PubMed ID: 932190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible nonspecific immunopotentiation by 2,4-dinitrochlorobenzene sensitization in patients with Hodgkin's disease.
    Rubinstein A; Ghossein NA; Melamed J; Bosworth JL; Murphy RA
    Oncology; 1979; 36(1):23-6. PubMed ID: 313034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hodgkin's disease: study of delayed hypersensitivity of 64 non treated patients. Value of epicutaneous test using croton oil].
    Goasguen J; Leblay R; Guerin D; Le Prise PY; Richier JL
    Sem Hop; 1977 Jan; 53(4):219-25. PubMed ID: 189435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's disease.
    Case DC; Hansen JA; Corrales E; Young CW; Dupont B; Pinsky CM; Good RA
    Cancer; 1976 Oct; 38(4):1807-15. PubMed ID: 1086708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.